MedTrace Logo

CMR for Prognosis Assessment in NSTEMI

NCT03516578 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 314

Last updated 2018-05-11

No results posted yet for this study

Summary

The prognostic significance of cardiac magnetic resonance (CMR) derived parameters of myocardial and microvascular injury has not been fully elucidated yet in non-ST-Elevation myocardial infarction (NSTEMI) patients. In the present study the investigators aim to comprehensively investigate the prognostic significance of CMR in a prospective, multicentre registry cohort of NSTEMI patients undergoing early percutaneous coronary intervention (PCI). CMR will be performed within the first week following the index event. The primary endpoint is defined as a composite of death, reinfarction, and new congestive heart failure (major adverse cardiac events) at 12 months.

Conditions

Interventions

OTHER

Cardiac magnetic resonance imaging

Sponsors & Collaborators

  • Heart Center Leipzig - University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-01
Primary Completion
2018-03-28
Completion
2018-03-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03516578 on ClinicalTrials.gov